Arocell AB
Records under this name other than the patents Arocell AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 3 of 3 · Back to Arocell AB
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,959,919 | Predicting cancer progression Term ended Term ended Jan 7, 2026 · From the USPTO record | Term ended | Term ended Jan 7, 2026 | From the USPTO record |
| US 10,551,385 | Predicting cancer progression Term ended Term ended May 14, 2024 · From the USPTO record | Term ended | Term ended May 14, 2024 | From the USPTO record |
| US 6,083,707 | Thymidine kinase TK1, peptide, corresponding antibodies and use of these in determination of tumor proliferation Term ended Term ended Oct 22, 2016 · From the USPTO record | Term ended | Term ended Oct 22, 2016 | From the USPTO record |